Virus News and Research

Latest Virus News and Research

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

Researchers examined immune reactions to SARS-CoV-2)among B cell-depleted autoimmune patients who concomitantly administered glucocorticoids.

18 Jul 2022

Boost now or wait? Many wonder how best to ride out covid’s next wave

Gwyneth Paige didn't want to get vaccinated against covid-19 at first. With her health issues — hypertension, fibromyalgia, asthma — she wanted to see how other people fared after the shots. Then her mother got colon cancer.

18 Jul 2022

Conservative blocs unleash litigation to curb public health powers

Through a wave of pandemic-related litigation, a trio of small but mighty conservative legal blocs has rolled back public health authority at the local, state, and federal levels, recasting America's future battles against infectious diseases.

18 Jul 2022

The characteristics of circulating T follicular helper cells in COVID-19 patients across mild to severe disease

Researchers found that late generation of functional SARS-CoV-2-selective circulating T follicular helper cells correlated with severe illness.

18 Jul 2022

How do different COVID-19 recovery paths impact health, food systems, and the environment?

Researchers investigated the effects of different recovery paths of COVID-19 on human health and environmental and food sustainability.

18 Jul 2022

Researchers assess the evolution and diversity of monkeypox virus genomes using phylogenomic analysis

In a recent study published in Travel Medicine and Infectious Disease, researchers phylogenomically analyzed the monkeypox virus.

18 Jul 2022

Novel nanoligomer approach to treat severe COVID-19

Researchers discuss the biodistribution and safety of a novel nanoligomer SBCoV207, which was used to targeted miR-2392 in a murine model.

17 Jul 2022

The potential of circular RNA COVID-19 vaccines

A new MedComm study describes the potential use of circular ribonucleic acid COVID-19 vaccines.

17 Jul 2022

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

As the coronavirus waves keep coming and cases are on the rise once again, the National Institutes of Health (NIH) recently launched a $577 million effort to develop antivirals against COVID-19 and other viruses with high pandemic potential.

15 Jul 2022

Best available chemotherapy for HIV-related Kaposi sarcoma would save lives and be cost-effective in Africa

Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in low- and middle-income countries.

15 Jul 2022

Quest Diagnostics starts testing for monkeypox with a real-time PCR test

Starting today, Quest Diagnostics will begin testing for monkeypox. The company has developed a real-time polymerase chain reaction (PCR) test that uses patient swab specimens to qualitatively detect non-variola orthpoxviruses and monkeypox virus DNA.

15 Jul 2022

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

Small proteins, called chemokines, that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study by researchers at Weill Cornell Medicine and Hospital for Special Surgery (HSS).

15 Jul 2022

WHO issues an urgent call to accelerate access to genomics in resource-poor countries

The World Health Organization (WHO) has issued an urgent call to accelerate access to genomics, especially in resource-poor countries, in a report that examines technology gaps and opportunities.

15 Jul 2022

California’s public health tax is dead for the year

A ballot initiative that would have raised taxes on California millionaires and billionaires to fund public health programs and pandemic prevention is dead — at least for this year.

15 Jul 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

Could the skills gained from military training help to tackle pandemics better?

Researchers have highlighted the skills developed from military training and services, which might be beneficial while responding to the current health crisis due to the COVID-19 pandemic.

15 Jul 2022

The role of the CDC in the management of COVID-19 vaccination programs

A team of CDC scientists has recently published an article in the journal Emerging Infectious Diseases to discuss the role of the CDC in the management of COVID-19 vaccination programs.

15 Jul 2022

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

A new mouse model identified by virologists from the University of Pittsburgh might revolutionize development of therapies targeting brain inflammation caused by Rift Valley Fever virus (RVFV).

15 Jul 2022

Viral DNA can be frequently detected in saliva, semen and other clinical samples from monkeypox-infected patients

Viral DNA can be frequently detected in different clinical samples from monkeypox-infected patients, including saliva and semen, according to a new study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, and the Hospital Clínic of Barcelona.

15 Jul 2022

Pox viruses deliver proteins that directly interfere with the body's innate immune system

Pox viruses are able to get a head start on infecting a host by delivering a package of proteins that directly interferes with the body's innate immune system.

15 Jul 2022

Virus News and Research

Latest Virus News and Research

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

Boost now or wait? Many wonder how best to ride out covid’s next wave

Conservative blocs unleash litigation to curb public health powers

The characteristics of circulating T follicular helper cells in COVID-19 patients across mild to severe disease

How do different COVID-19 recovery paths impact health, food systems, and the environment?

Researchers assess the evolution and diversity of monkeypox virus genomes using phylogenomic analysis

Novel nanoligomer approach to treat severe COVID-19

The potential of circular RNA COVID-19 vaccines

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

Best available chemotherapy for HIV-related Kaposi sarcoma would save lives and be cost-effective in Africa

Quest Diagnostics starts testing for monkeypox with a real-time PCR test

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

WHO issues an urgent call to accelerate access to genomics in resource-poor countries

California’s public health tax is dead for the year

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Could the skills gained from military training help to tackle pandemics better?

The role of the CDC in the management of COVID-19 vaccination programs

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

Viral DNA can be frequently detected in saliva, semen and other clinical samples from monkeypox-infected patients

Pox viruses deliver proteins that directly interfere with the body's innate immune system

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in